Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Horizontal platelet-rich fibrin (H-PRF) is an autologous blood-derived biologic used primarily in regenerative dentistry and oral surgery to enhance soft and hard tissue healing. It is produced by centrifuging a patient's whole blood in a horizontal centrifuge, which allows for a more distinct separation of blood components compared to traditional fixed-angle centrifugation. This process results in a fibrin matrix with a higher concentration of platelets, leukocytes, and growth factors (such as PDGF, TGF-β, and VEGF) distributed throughout the clot. H-PRF acts as a scaffold for cell migration and a reservoir for the sustained release of bioactive molecules, promoting angiogenesis and tissue regeneration at surgical sites like palatal donor sites or third molar extraction sockets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on horizontal platelet-rich fibrin.